PAAMCP
RIGL icon

Pacific Alternative Asset Management Company (PAAMCO)’s Rigel Pharmaceuticals RIGL Stock Holding History

Pacific Alternative Asset Management Company (PAAMCO)’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,708
Closed -$66K – 222
2014
Q1 		$66K Sell
1,708
-10,431
-86% -$372K 0.01% 158
2013
Q4 		$346K Buy
+12,139
New +$356K 0.12% 83

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pacific Alternative Asset Management Company (PAAMCO)'s RIGL Position: Q2 2014 in Review

Pacific Alternative Asset Management Company (PAAMCO) sold out of Rigel Pharmaceuticals (RIGL) in Q2 2014, closing a stake of 1,708 shares — an estimated $66K sold.

Pacific Alternative Asset Management Company (PAAMCO) first reported a position in RIGL in Q4 2013 and held it in 2 quarters. The position peaked at $346K in Q4 2013. 103 funds tracked by Wall St. Rank hold RIGL as of Q2 2014.

  • Pacific Alternative Asset Management Company (PAAMCO) reported no remaining Rigel Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Pacific Alternative Asset Management Company (PAAMCO) sold 1,708 Rigel Pharmaceuticals shares in Q2 2014, an estimated $66K.
  • Pacific Alternative Asset Management Company (PAAMCO) first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • Pacific Alternative Asset Management Company (PAAMCO)'s Rigel Pharmaceuticals position peaked at $346K in Q4 2013.
  • 103 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2014.

Based on Pacific Alternative Asset Management Company (PAAMCO)'s 13F filing for Q2 2014, filed 12 Aug 2014.